Disease-specific assays
16 January, 2006HealthLinx has entered into a collaboration with Bruker Daltonics, which will focus on technology transfer and cooperation between the two firms to develop disease-specific assays for use in in-vitro diagnostic (IVD) research and clinical trials using Bruker Daltonics' ClinProt platform technology for clinical proteomics.
Kidney stone analysis using FTIR spectrometry
08 January, 2006A Kidney Stone Library & Analysis Kit has been developed to assist in the identification and characterisation of kidney stones by spectral analysis
Screening test for infant iron deficiency
28 October, 2005A new blood test detects iron deficiency in infants earlier and more accurately than the commonly used haemoglobin screening test, according to a study in the August 24/31 issue of the Journal of the American Medical Association. Iron deficiency is estimated to affect nearly 10% of American children one to two years of age. Early detection and treatment are critical because iron deficiency can impair infant mental development, possibly permanently, even before it progresses to anaemia.
Testing methods for monkeypox and smallpox
23 October, 2005Researchers at the Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University have developed new diagnostic methods to better detect future monkeypox or smallpox outbreaks. The research also sheds new light on the 2003 monkeypox outbreak in the US - monkeypox is closely related to smallpox. This new information suggests that the 2003 outbreak was larger than the 72 cases reported by the Centers for Disease Control and Prevention (CDC).
Detecting inflammatory cells in blood vessels
22 October, 2005Atherosclerotic plaque typically builds up without symptoms and the search is on to develop early detection devices that will enable physicians to offer treatment before the disease progresses to advanced stages.
Quicker, less invasive cancer detection
17 October, 2005A Mississippi State research team is developing a cancer screening process that may allow physicians to more quickly diagnose malignancies without performing invasive biopsies. Utilising laser-induced breakdown spectroscopy, or LIBS, scientists are seeking to precisely distinguish malignant and normal cells in real time by inserting a single optical fibre microprobe directly into suspicious tissue for a cancer diagnosis, including breast cancer.
Childhood epilepsy test
10 August, 2005Bionomics has presented the results of a 239 patient clinical study of childhood epilepsy. The University of Melbourne's Associate Professor Ingrid Scheffer presented the results to an invited symposium on epilepsy research.
Pre-eclampsia test development
10 August, 2005Beckman Coulter has announced it has signed a licensing agreement with Nephromics, LLC. The agreement provides Beckman Coulter access to all Nephromics' patents, patent applications and biologics related to the detection, monitoring and risk assessment of pre-eclampsia, which is the second leading cause of maternal deaths in the developed world.
Cornering cholera
22 May, 2005A new treatment for the age-old scourge of cholera and perhaps a whole new type of antibiotic medicine may emerge from chemicals discovered in an Australian seaweed, new research results suggest.
Maybe not a 'pox on you'
23 September, 2004A breakthrough in identifying the mechanisms that control mousepox could pave the way to better protection against the use of smallpox by terrorists.
Osteoarthritis measuring tool
20 September, 2004Researchers from Monash University's Department of Epidemiology and Preventive Medicine are claiming to have revolutionised knee scans with the development of technology that harnesses the power of magnetic resonance imaging (MRI).
